Status:
NOT_YET_RECRUITING
Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
Lead Sponsor:
Peking University Third Hospital
Conditions:
Early Gastric Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
In this study, patients who are going to undergo endoscopic submucosal dissection (ESD) or surgery for early gastric cancer will be enrolled and divided into ESD group and Surgery group according to t...
Eligibility Criteria
Inclusion
- Clinically diagnosed as early gastric cancer
- Willing to undergo endoscopic submucosal dissection or surgery for the treatment of early gastric cancer
Exclusion
- Advanced stage gastric cancer
- Not willing to undergo endoscopic submucosal dissection or surgery for the treatment of early gastric cancer
- Not willing to participate in this study
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03857737
Start Date
March 1 2019
End Date
December 31 2029
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100091